Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/44706
Title: Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain
Author: Cristobal, Ignacio
Febrer, Laia
Crespo, Carlos
Arbat, Agnès
Hernandez, Francisco J.
Brosa, M.
Keywords: Ginecologia
Anàlisi econòmica
Espanya
Gynecology
Economic analysis
Spain
Issue Date: 2011
Publisher: Elsevier B.V.
Abstract: To compare the cost and effectiveness of the levonorgestrel-releasing intrauterine system (LNG-IUS) versus combined oral contraception (COC) and progestogens (PROG) in first-line treatment of dysfunctional uterine bleeding (DUB) in Spain. STUDY DESIGN: A cost-effectiveness and cost-utility analysis of LNG-IUS, COC and PROG was carried out using a Markov model based on clinical data from the literature and expert opinion. The population studied were women with a previous diagnosis of idiopathic heavy menstrual bleeding. The analysis was performed from the National Health System perspective, discounting both costs and future effects at 3%. In addition, a sensitivity analysis (univariate and probabilistic) was conducted. RESULTS: The results show that the greater efficacy of LNG-IUS translates into a gain of 1.92 and 3.89 symptom-free months (SFM) after six months of treatment versus COC and PROG, respectively (which represents an increase of 33% and 60% of symptom-free time). Regarding costs, LNG-IUS produces savings of 174.2-309.95 and 230.54-577.61 versus COC and PROG, respectively, after 6 months-5 years. Apart from cost savings and gains in SFM, quality-adjusted life months (QALM) are also favourable to LNG-IUS in all scenarios, with a range of gains between 1 and 2 QALM compared to COC and PROG. CONCLUSIONS: The results indicate that first-line use of the LNG-IUS is the dominant therapeutic option (less costly and more effective) in comparison with first-line use of COC or PROG for the treatment of DUB in Spain. LNG-IUS as first line is also the option that provides greatest health-related quality of life to patients.
Note: Versió postprint del document publicat a: http://dx.doi.org/10.1016/j.ejogrb.2010.08.019
It is part of: European Journal Of Obstetrics & Gynecology And Reproductive Biology, 2011, vol. 154, num. 1, p. 71-80
Related resource: http://dx.doi.org/10.1016/j.ejogrb.2010.08.019
URI: http://hdl.handle.net/2445/44706
ISSN: 0301-2115
Appears in Collections:Articles publicats en revistes (Genètica, Microbiologia i Estadística)

Files in This Item:
File Description SizeFormat 
579141.pdf584.04 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.